首页> 中国专利> 咪唑立宾以及包含咪唑立宾的组合物的用途

咪唑立宾以及包含咪唑立宾的组合物的用途

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明涉及咪唑立宾以及包含咪唑立宾的组合物的用途，具体提供了咪唑立宾以及包含咪唑立宾的组合物用于治疗和预防角膜新生血管化、角膜纤维化、翼状胬肉、睑板腺功能障碍和视疲劳的用途。

著录项

公开/公告号CN112220749A

专利类型发明专利
公开/公告日2021-01-15

原文格式PDF
申请/专利权人厦门上佳源生物科技有限公司;
展开▼

申请/专利号CN202011170497.3
发明设计人刘祖国;林祥;
展开▼

申请日2020-10-28
分类号A61K9/08(20060101);A61K31/7056(20060101);A61K47/02(20060101);A61K47/18(20060101);A61P27/02(20060101);A61P27/10(20060101);
代理机构11038 中国贸促会专利商标事务所有限公司;
代理人崔锡强
地址 361102 福建省厦门市翔安区新店镇洞庭路7号2726单元
入库时间 2023-06-19 09:35:27

法律信息

法律状态公告日

法律状态信息

法律状态
2022-11-29

授权

发明专利权授予

相似文献

专利
中文文献
外文文献

1. 咪唑立宾以及包含咪唑立宾的组合物的用途 [P] . 中国专利： CN112220749A . 2021-01-15
2. 介电凝胶组合物、这种介电凝胶组合物的用途、包含这种凝胶组合物的绝缘DC－电缆以及制造包含这种凝胶组合物的绝缘DC－电缆的方法 [P] . 中国专利： CN1285075A . 2001-02-21
3. isolated monoclonal antibodies; monoclonal antibodies or antigen binding fragments thereof; composition; isolated polynucleotide molecules; recombinant polypeptide; polypeptides; host cell; method of making an antibody; use of an agent for treating cancer in a patient; uses of monoclonal antibody or antigen-binding fragment thereof for the treatment of a subject suffering from cancer; use of monoclonal antibody to treat a subject suffering from cancer; a composition comprising an agr2 binding antibody; a composition comprising a c4.4a binding antibody; a composition comprising an agr2 binding antibody and a c4.4a binding antibody; composition comprising an antibody; use of an agr2 binding antibody; use of a c4.4a binding antibody; use of an antibody; and kit comprising an antibody [P] . BR112017004510A2 . 2018-01-23

机译：分离的单克隆抗体;单克隆抗体或其抗原结合片段;组成;分离的多核苷酸分子;重组多肽多肽;宿主细胞;制备抗体的方法;药剂用于治疗患者的癌症的用途;单克隆抗体或其抗原结合片段在治疗癌症患者中的用途;单克隆抗体在治疗患有癌症的受试者中的用途;包含agr2结合抗体的组合物;包含c4.4a结合抗体的组合物;包含agr2结合抗体和c4.4a结合抗体的组合物;包含抗体的组合物;使用agr2结合抗体;使用c4.4a结合抗体;抗体的使用;和包含抗体的试剂盒
4. isolated monoclonal antibodies; monoclonal antibodies or antigen binding fragments thereof; composition; isolated polynucleotide molecules; recombinant polypeptide; polypeptides; host cell; method of making an antibody; use of an agent for treating cancer in a patient; uses of monoclonal antibody or antigen-binding fragment thereof for the treatment of a subject suffering from cancer; use of monoclonal antibody to treat a subject suffering from cancer; a composition comprising an agr2 binding antibody; a composition comprising a c4.4a binding antibody; a composition comprising an agr2 binding antibody and a c4.4a binding antibody; composition comprising an antibody; use of an agr2 binding antibody; use of a c4.4a binding antibody; use of an antibody; and kit comprising an antibody [P] . BR112017004510A8 . 2018-06-26

机译：分离的单克隆抗体;单克隆抗体或其抗原结合片段;组成;分离的多核苷酸分子;重组多肽多肽;宿主细胞;制备抗体的方法;药剂用于治疗患者的癌症的用途;单克隆抗体或其抗原结合片段在治疗癌症患者中的用途;单克隆抗体在治疗患有癌症的受试者中的用途;包含agr2结合抗体的组合物;包含c4.4a结合抗体的组合物;包含agr2结合抗体和c4.4a结合抗体的组合物;包含抗体的组合物;使用agr2结合抗体;使用c4.4a结合抗体;抗体的使用;和包含抗体的试剂盒
5. Recombinant allergen, the use of the recombinant allergen, a composition containing two or more variants of recombinant mutant allergens, the use of that composition, a pharmaceutical composition containing the recombinant allergen or the said composition, the use of the recombinant allergen, composition or pharmaceutical composition, a method for preparing the pharmaceutical composition, a method for preparing the recombinant allergen, a method for preparing a library of the recombinant allergen, DNA sequence encoding the recombinant allergen, expression vector comprising that DNA, host cell containing that expression vector, a method for obtaining recombinant mutant allergen, and diagnostic method to assess the suitability, safety or outcome of the therapy [P] . PL212139B1 . 2012-08-31

机译：重组变应原，重组变应原的用途，含有两种或更多种重组突变变应原的变体的组合物，该组合物的用途，含有重组变应原或所述组合物的药物组合物，重组变应原的用途，组合物或药物组合物，制备药物组合物的方法，制备重组变应原的方法，制备重组变应原的文库，编码重组变应原的DNA序列，包含该DNA的表达载体，包含该表达载体的宿主细胞，获得重组突变体变应原的方法，以及评估该疗法的适用性，安全性或结果的诊断方法